HK1203159A1 - Prophylactic agent and or therapeutic agent for stress urinary incontinence - Google Patents
Prophylactic agent and or therapeutic agent for stress urinary incontinenceInfo
- Publication number
- HK1203159A1 HK1203159A1 HK15103765.0A HK15103765A HK1203159A1 HK 1203159 A1 HK1203159 A1 HK 1203159A1 HK 15103765 A HK15103765 A HK 15103765A HK 1203159 A1 HK1203159 A1 HK 1203159A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- agent
- urinary incontinence
- stress urinary
- therapeutic agent
- prophylactic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
- C07D211/50—Aroyl radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012111843 | 2012-05-15 | ||
PCT/JP2013/063409 WO2013172339A1 (fr) | 2012-05-15 | 2013-05-14 | Agent prophylactique et/ou agent thérapeutique pour l'incontinence urinaire d'effort |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1203159A1 true HK1203159A1 (en) | 2015-10-23 |
Family
ID=49583744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15103765.0A HK1203159A1 (en) | 2012-05-15 | 2015-04-17 | Prophylactic agent and or therapeutic agent for stress urinary incontinence |
Country Status (9)
Country | Link |
---|---|
US (1) | US9603845B2 (fr) |
EP (1) | EP2851073B1 (fr) |
JP (1) | JP5908072B2 (fr) |
CN (1) | CN104302293B (fr) |
ES (1) | ES2612827T3 (fr) |
HK (1) | HK1203159A1 (fr) |
PL (1) | PL2851073T3 (fr) |
TW (1) | TWI544925B (fr) |
WO (1) | WO2013172339A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004033693A1 (fr) | 2002-03-29 | 2004-04-22 | Xoma Technology Ltd. | Plasmides de vecteurs multigeniques et methodes d'accroissement de l'expression de polypeptides recombinants |
WO2020101586A1 (fr) | 2018-11-16 | 2020-05-22 | Santa Farma İlaç Sanayi̇ A.Ş. | Formulations de propivérine à libération contrôlée |
EP4251154A1 (fr) | 2020-11-27 | 2023-10-04 | Santa Farma Ilac Sanayii A.S. | Compositions de formulation à libération prolongée comprenant de la propivérine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD139212A1 (de) | 1978-10-09 | 1979-12-19 | Christian Starke | Verfahren zur herstellung eines neuen arzneimittels aus alpha,alpha-diphenyl-alpha-alkoxyessigsaeure-1-methylpiperidyl-4-ester-derivaten |
JPH0611758B2 (ja) * | 1985-08-14 | 1994-02-16 | 大鵬薬品工業株式会社 | ベンジル酸−4−ピペリジルエステル誘導体 |
-
2013
- 2013-05-14 PL PL13790782T patent/PL2851073T3/pl unknown
- 2013-05-14 WO PCT/JP2013/063409 patent/WO2013172339A1/fr active Application Filing
- 2013-05-14 TW TW102117019A patent/TWI544925B/zh active
- 2013-05-14 CN CN201380023152.7A patent/CN104302293B/zh active Active
- 2013-05-14 JP JP2014515634A patent/JP5908072B2/ja active Active
- 2013-05-14 EP EP13790782.0A patent/EP2851073B1/fr active Active
- 2013-05-14 ES ES13790782.0T patent/ES2612827T3/es active Active
- 2013-05-14 US US14/388,289 patent/US9603845B2/en active Active
-
2015
- 2015-04-17 HK HK15103765.0A patent/HK1203159A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
PL2851073T3 (pl) | 2017-06-30 |
ES2612827T3 (es) | 2017-05-18 |
EP2851073A4 (fr) | 2015-10-28 |
US20150051250A1 (en) | 2015-02-19 |
US9603845B2 (en) | 2017-03-28 |
CN104302293A (zh) | 2015-01-21 |
WO2013172339A1 (fr) | 2013-11-21 |
TWI544925B (zh) | 2016-08-11 |
EP2851073B1 (fr) | 2016-11-09 |
EP2851073A1 (fr) | 2015-03-25 |
CN104302293B (zh) | 2017-03-15 |
TW201350118A (zh) | 2013-12-16 |
JPWO2013172339A1 (ja) | 2016-01-12 |
JP5908072B2 (ja) | 2016-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181615T1 (hr) | Terapijsko sredstvo koje izaziva citotoksičnost | |
HK1245130A1 (zh) | 酶組合物及其用於創傷愈合的用途 | |
IL222702A0 (en) | Incontinence treatment | |
EP2709562A4 (fr) | Dispositifs de maintien de tissus et procédés d'utilisation | |
EP2785275A4 (fr) | Traitement de l'incontinence urinaire | |
HK1243921A1 (zh) | 用於緩解尿頻的延長釋放製劑及其使用方法 | |
IL232715A0 (en) | The delayed-release composition for reducing the frequency of urination and a method for using it | |
HK1167942A1 (en) | Self-testing transceiver and self-testing method thereof | |
HK1206987A1 (en) | Prophylactic and or therapeutic agent for radiation damage | |
IL222479A0 (en) | Devices and methods for tissue engineering | |
EP2931140A4 (fr) | Dispositifs et procédés de réparation de tissus | |
EP2529739A4 (fr) | Agent thérapeutique ou prophylactique pour les maladies biliaires | |
HK1249438A1 (zh) | 用於緩解尿頻的緩釋製劑及其使用方法 | |
EP2663343A4 (fr) | Dispositifs et procédés d'ingénierie tissulaire | |
EP2708233A4 (fr) | Ctrp6 qui peut être utilisée à titre d'agent thérapeutique et prophylactique pour les maladies auto-immunes | |
HK1203159A1 (en) | Prophylactic agent and or therapeutic agent for stress urinary incontinence | |
HK1248549A1 (zh) | 用於緩解尿頻的延長釋放製劑及其使用方法 | |
EP2745838A4 (fr) | Agent prophylactique et/ou agent thérapeutique pour la septicémie | |
ZA201406668B (en) | Pharmaceutical composition for treating urinary incontinence and enuresis | |
HK1202260A1 (en) | Agent for preventing and or treating veisalgia | |
EP2626069A4 (fr) | Médicament destiné à la prévention et au traitement d'un lymph dème | |
GB201011456D0 (en) | Compositions and methods for embolization therapy | |
GB201003727D0 (en) | Therapeutic agent |